MedTrace Logo

Positron Emission Tomography-computed Tomography (PET-CT) for Main & Branch Intraductal Papillary Mucinous Neoplasm

NCT00988416 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 69

Last updated 2016-07-13

No results posted yet for this study

Summary

The purpose of the study is to prove the hypothesis that pancreas PET-CT can differentiate duct involved IPMN with malignancy from duct involved non-malignant IPMN.

Conditions

  • Intraductal Papillary Mucinous Neoplasm

Interventions

PROCEDURE

PET-CT

Pancreas Protocol PET-CT

Sponsors & Collaborators

  • Indiana University

    lead OTHER

Principal Investigators

  • Christian M Schmidt, MD · Indiana University

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2016-04-30
Completion
2016-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00988416 on ClinicalTrials.gov